NUI Galway Researcher Wins International Wound Care Award

NUI Galway PhD student, Andrea Mahon (centre) is presented with the Journal of Wound Care Award for The Best Laboratory/Pre-Clinical Study. Also pictured is Dr Samantha Westgate, CEO of Perfectus Biomed who sponsored the award and Corporal Terry Byrne of the 2nd Battalion Parachute Regiment and host of the ceremony.
Mar 08 2016 Posted: 15:05 GMT

Andrea Mahon, a PhD student in the Discipline of Podiatric Medicine at NUI Galway was recently awarded a prestigious Journal of Wound Care Award for The Best Laboratory/Pre-Clinical Study. This achievement was in recognition of research undertaken in fulfillment of her Masters by Research degree and was presented at a special ceremony in London.

To address the need for advanced wound therapies; Andrea designed a preclinical study to assess topical stem cell therapy in a diabetic wound model. A stem cell clinical trial in diabetic foot ulcers will be planned by the outcome of this research.

From Oranmore, Co. Galway, Andrea’s research was supervised by Professor Caroline McIntosh, Head of Discipline of Podiatric Medicine, Professor Timothy O’Brien, Dean of the College of Medicine, Nursing and Health Sciences and Dr Claire MacGilchrist, Lecturer in Podiatric Medicine.

The Journal of Wound Care Awards recognises innovation and excellence in research and practice within the field of wound care. The aim is to recognise individuals and teams who have improved, implemented or excelled in some field of wound care.

Professor Caroline McIntosh said: “This is a fabulous achievement which highlights the high quality of research being undertaken in wound healing and tissue repair at NUI Galway. Diabetes is one of the leading causes of lower limb ulceration and amputation. Diabetes related foot ulcers are challenging to manage with many failing to respond to standard wound therapies. There is a need to research advanced therapies for application on non-healing wounds. The findings of Andrea’s research will help in the design of first in human studies of Mesenchymal stem cell application for non-healing neuropathic diabetic foot ulcers.”


Marketing and Communications Office


Featured Stories